There was also a systematic tendency to have larger proportions of CD14 monocytes in COVID-19 (on average 30%–38%) than in controls (on average 15%–23%, p < 0.001 in Combes, p < 0.1 in Wilk, p = 0.2 in Lee data, Supplementary Table S4). Here, CD14 is linked to COVID-19.